LabPMM® Launches Global KMT2A MRD Testing Service to Support Menin Inhibitor Development and Acute Leukemia Carecreated_atAug 4, 2026, 8:21 AM UTCingested_atAug 4, 2026, 8:21 AM UTCprovidersgdeltsourcethestarphoenix.comprovider_count1source_slugthestarphoenix-comurlhttps://thestarphoenix.com/press-releases/business-wire/labpmm-launches-global-kmt2a-mrd-testing-service-to-support-menin-inhibitor-development-and-acute-leukemia-carecountryCanadalanguageEnglishorg_idmycompanylist.comdedup_keyf9d2a3eaafbc6206keywordsacute leukemia, development acute, global kmt2a, inhibitor development, kmt2a mrd, labpmm launches, launches global, leukemia care, menin inhibitor, mrd testing, service support, support meninlast_modified_atAug 4, 2026, 8:21 AM UTCprovidergdeltfeed_sectionWorldpublished_atAug 4, 2026, 8:00 AM UTCRelatedMoneySimpler Launches No-Code AI Automated Trading to Simplify Retirement Planning and Social Security Benefits – IT Business NetStep inside Shekhar Ravjiani Khandala bungalow that looks like a lavish eco-resort with Parsi charm, valley viewsWarmySender AI Outreach Lets Marketers Run Cold-Email, LinkedIn, and Instagram Outreach on Autopilot With AI Agents Such as ChatGPT and Claude – IT Business Net蕭景鴻憶亡父痛哭 寫歌傳遞思念-星島日報Amundi MSCI united kingdom IMI SRI Climate Paris Aligned UCITS ETF GBP Acc: Net Asset Value (s)Retail Investor Presentation via IMC | Company Announcement